Literature DB >> 2843940

Peripheral cholangiocarcinoma and clonorchiasis: CT findings.

B I Choi1, J H Park, Y I Kim, E S Yu, S H Kim, W H Kim, C Y Kim, M C Han.   

Abstract

Sixteen patients with peripheral cholangiocarcinoma of the liver were examined with computed tomography (CT). None of the 16 patients presented with jaundice or had documented cirrhosis. On scans obtained both before and after the injection of contrast material, the tumors were depicted as low-attenuation masses in all cases, with wide variations in homogeneity. The tumor margin was irregular in 12 cases, and there was minimal contrast enhancement of the tumor in 14 cases. In 11 (69%) patients, CT demonstrated masses of markedly low attenuation, which corresponded to areas of diffuse microcystic change seen at histologic examination of resected specimens. In ten (63%) patients, the results of stool or intradermal tests for Clonorchis sinensis were positive. In all ten cases of clonorchiasis, mild, diffuse dilatation of the intrahepatic bile ducts was seen in addition to the low-attenuation masses, but there was no dilatation of the extrahepatic biliary tree. In five of the ten patients with clonorchiasis, stippled or aggregated, powderlike areas of high attenuation were seen on precontrast CT scans; at pathologic examination, those areas were found to be mucin. Extrahepatic metastases were demonstrated in ten (63%) patients. Peripheral cholangiocarcinoma should be the primary diagnostic consideration when these characteristic CT findings are detected in a noncirrhotic patient.

Entities:  

Mesh:

Year:  1988        PMID: 2843940     DOI: 10.1148/radiology.169.1.2843940

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  Changes in sonographic findings after treatment of patients with clonorchiasis in a heavy endemic area.

Authors:  Dongil Choi; Yong Hwan Jeon; Geun-Chan Lee; Min-Ho Choi; Sung-Tae Hong
Journal:  Korean J Parasitol       Date:  2009-03-12       Impact factor: 1.341

2.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.

Authors:  J R Madariaga; S Iwatsuki; S Todo; R G Lee; W Irish; T E Starzl
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

Review 3.  Imaging diagnosis of clonorchiasis.

Authors:  Dongil Choi; Sung Tae Hong
Journal:  Korean J Parasitol       Date:  2007-06       Impact factor: 1.341

4.  Peripheral cholangiocarcinoma: comparison of MRI with CT.

Authors:  B I Choi; J K Han; Y M Shin; S Y Baek; M C Han
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

Review 5.  Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.

Authors:  Byung Ihn Choi; Joon Koo Han; Sung Tae Hong; Kyoung Ho Lee
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Sclerosing hepatocellular carcinoma: radiologic findings.

Authors:  Y Yamashita; Z M Fan; H Yamamoto; T Matsukawa; A Arakawa; T Miyazaki; M Harada; M Takahashi
Journal:  Abdom Imaging       Date:  1993

7.  Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey.

Authors:  Ho Gak Kim; Jimin Han; Myung-Hwan Kim; Kyu Hyun Cho; Im Hee Shin; Gwang Ha Kim; Jae Seon Kim; Jin Bong Kim; Tae Nyeun Kim; Tae Hyeon Kim; Tae Hyo Kim; Jae Woo Kim; Ji Kon Ryu; Young Soo Moon; Jong Ho Moon; Sung Jae Park; Chan Guk Park; Sung-Jo Bang; Chang Heon Yang; Kyo-Sang Yoo; Byung Moo Yoo; Kyu Taek Lee; Dong Ki Lee; Byung Seok Lee; Sang Soo Lee; Seung Ok Lee; Woo Jin Lee; Chang Min Cho; Young-Eun Joo; Gab Jin Cheon; Young Woo Choi; Jae Bok Chung; Yong Bum Yoon
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

8.  Cystic peripheral cholangiocarcinoma: sonography and CT.

Authors:  S K Lee; B I Choi; J M Cho; J K Han; Y I Kim; M C Han
Journal:  Abdom Imaging       Date:  1995 Mar-Apr

9.  MR imaging of intrahepatic cholangiocarcinoma.

Authors:  P Soyer; D A Bluemke; A Sibert; J P Laissy
Journal:  Abdom Imaging       Date:  1995 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.